about
SPECT/CT imaging of the lumbar spine in chronic low back pain: a case report.An appraisal of 18F-FDG PET imaging in post-therapy surveillance of uterine cancers: clinical evidence and a research proposal.Transbilayer phospholipids molecular imaging.The imaging of apoptosis with the radiolabelled annexin A5: a new tool in translational research.18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.A plea for the elective inclusion of the brain in routine whole-body FDG PET.A case of cerebral metastases of unknown origin: utility of F-18 FDG positron emission tomography to localize the primary tumor.Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma.Contribution of whole-body 18FDG PET imaging in the management of cervical cancer.Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease.Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome).Evaluation of pleural disease with 18-fluorodeoxyglucose positron emission tomography imaging.The right place of 18FDG PET for the diagnosis of giant cell arteritis--a response to the article of Brodmann et al.Accuracy of quantitative reconstructions in SPECT/CT imaging.In vivo imaging of chemotherapy-induced apoptosis in human cancers.Gamma-probe-directed lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma.Differentiated thyroid cancer with epiphora: detection of nasolacrimal duct obstruction on I-131 SPECT/CT.Detection of 99mTc-sestamibi uptake in brown adipose tissue with SPECT-CT.Typical appearance of mesothelioma on an F-18 FDG positron emission tomographNuclear medicine in the era of genomics and proteomics: lessons from annexin VComplementary roles of low-dose SPECT-CT and high-resolution volume CT for detection of coronary artery disease
P50
Q34577600-67865B8D-CBAE-4F5E-822E-0B31658C553DQ35092175-B6EA550C-7038-43C3-85EB-7A9F8D24251BQ35650805-D1F00144-0800-4680-88B9-72164D22BA69Q37230168-88716415-2F75-40B3-8239-A4939FB9049BQ37918311-D81D6E0D-7ABB-4CAA-B595-EAEBF2C4B6A5Q43508709-7B779946-C819-4DA9-A68D-02746C0D60B7Q43708679-A73F928E-F37E-4FE1-9853-13BE49A4B859Q44112070-7CF4A532-BD23-41C0-B317-BDBAF6988BD2Q44240223-243AE91F-BBDF-4843-8EAA-E1C3DD9B635AQ44253359-2C7ED5A0-7E6E-4BB9-8AF9-77AEDEAF4639Q44595488-91DA5C5F-75CF-4D03-8191-11EFC0D7FD52Q44760414-F57F2218-B67F-4E26-9FD1-980EAADCD1A2Q44855030-B9E6C888-C031-4665-84C7-C4C4B762C34DQ47416547-B0BC427F-7631-4090-B42A-BB57A6FB6565Q47916671-D19377B9-DF74-48F4-BEAB-4D303BA2C7B6Q50499677-3450F9EC-ADCB-4D19-BDCC-22A1BE961CFEQ53192792-1CFC0C20-3886-43C2-AE76-955BDD0C117DQ53517975-534FD59B-944F-412B-874B-F4A6DDAD9578Q74176356-4A46BBB9-BCE7-4087-B71F-4C5DF2355F11Q80340071-B7FA73B2-55E7-4BED-AF74-F784356DFF5EQ80925796-4723AD20-1EC6-479D-B220-FFA028AA8B8D
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Belhocine T
@ast
Belhocine T
@es
Belhocine T
@nl
Belhocine T
@sl
Tarik-Zine Belhocine
@en
type
label
Belhocine T
@ast
Belhocine T
@es
Belhocine T
@nl
Belhocine T
@sl
Tarik-Zine Belhocine
@en
altLabel
Belhocine T
@en
Belhocine TZ
@en
prefLabel
Belhocine T
@ast
Belhocine T
@es
Belhocine T
@nl
Belhocine T
@sl
Tarik-Zine Belhocine
@en
P1053
D-4597-2013
P106
P1153
7003393672
P31
P3829
P496
0000-0002-3234-9480